Interstitial lung disease: Difference between revisions

Revision as of 15:46, 18 February 2023

@@ Line 2: / Line 2: @@
 * Primary
-** IPF
+** [[IPF]]
-** COP
+** [[COP]]
-** NSIP
+** [[NSIP]]
 * Secondary
 ** Inflammatory or connective tissue diseases
-*** Rheumatoid arthritis
+*** [[Rheumatoid arthritis]]
-*** Systemic lupus erythematosus
+*** [[Systemic lupus erythematosus]]
-*** Dermatomyositis
+*** [[Dermatomyositis]]
-*** Systemic sclerosis
+*** [[Systemic sclerosis]]
-*** Sarcoidosis
+*** [[Sarcoidosis]]
 ** Exposures
-*** Hypersensitivity pneumonitis
+*** [[Hypersensitivity pneumonitis]]
 *** Inorganic
 **** Silica
@@ Line 20: / Line 20: @@
 **** [[Nitrofurantoin]]
 **** Chemotherapy
-***** Cyclophosphamide
+***** [[Cyclophosphamide]]
 ***** Others
-**** Methotrexate
+**** [[Methotrexate]]
 *** Organic
 **** Occupational and hobby lung diseases
-*** Radiation pneumonitis
+*** [[Radiation pneumonitis]]
 * Mimickers
-** Congestive heart failure
+** [[Congestive heart failure]]
 ** Interstitial infections
 *** [[Pneumocystis jirovecii pneumonia]]
@@ Line 33: / Line 33: @@
 *** [[Legionella]]
 *** Viral pneumonia
-** Lymphangitic carcinomatosis
+** [[Lymphangitic carcinomatosis]]
 [[Category:Respirology]]